International Cannabis Weekly: 378

UK CBD INDUSTRY SEES LIGHT AT THE END OF THE TUNNEL: FIRST AUTHORISED PRODUCTS EXPECTED BY SPRING 2025

In a long-awaited and major step forward for the UK’s CBD sector, the regulator has announced a new roadmap that could see the first products given official approval.

READ MORE  »

DEA’S CANNABIS RESCHEDULING HEARING SET TO BEGIN IN JANUARY

READ MORE »

CZECH GPs WILL BE ABLE TO PRESCRIBE MEDICAL CANNABIS STARTING FROM NEXT YEAR

READ MORE »

• Ananda expands cannabis trials in the UK, aiming to meet regulators at critical needs.
• CBD starting to show promise as a new treatment option for endometriosis sufferers.
• Shaping Germany’s cannabis future: Insights from Business of Cannabis Berlin Executive Summit.
• Releaf’s training standards raise the bar for medical cannabis compliance across UK.
• France’s strict cannabis laws remain despite Europe’s highest consumption rates nationally.
• Flora Growth Corp. has renewed sales orders with Mirfa s.r.o. for the Czech Republic and Slovakia markets.

FIND OUT MORE »

• Blimburn Seeds announces global partnership with cannabis pioneer Steve DeAngelo as ambassador.
• Project Champion helps underserved cannabis farmers comply with regulations and boost market success.
• NAACP urges New York governor to prioritise equity over big cannabis corporations.
• USDA modifies hemp insurance, revising crop rotation rules and excluding smoke damage coverage.
• Nebraska attorney general plans Supreme Court challenge to voter-approved medical marijuana measures.
• Nevis Brands expands cannabis beverage licensing, targeting new markets with diverse product offerings.

• Quebec’s SQDC introduces cannabis vaping products to expand options for local consumers.
• High Tide launches new membership program across UK, US, and EU with products.
• HYTN secures UK import permits and prepares shipments for international export markets.
• Avicanna delivers proprietary cannabis products to multinational pharmaceutical company as distribution expands.
• Entourage Health improves revenue by 8% and reduces losses in its latest quarter.
• Health Canada cannabis program faces $20 million budget reductions over three years.

• Brazil surpasses 672,000 patients receiving medical cannabis treatments under expanding healthcare program.
• Brazilian cannabis parliamentary front announces selected projects from 2024 government funding initiative.
• Costa Rica cancels proposed referendum on legalising recreational cannabis, citing public opposition concerns.
• New provincial program promotes therapeutic cannabis use with enhanced access and resources available.

• Gro Vida secures Australian market partnership with Lyphe to grow medical cannabis offering.
• Rua Bioscience seeks $3 million funding to expand medicinal cannabis development operations.

• Israeli Economy Ministry unveils plans to expand the competiviness of its cannabis market.
• South Africa’s cannabis reform celebrated as industry marks key milestones and growth potential.